Bioneer is collaborating with the Cardiology Stem Cell Centre (CSCC) based at Rigshospitalet, Copenhagen University Hospital, on analyzing potency of Mesenchymal Stromal Cells (MSCs). Together, Bioneer and CSCC have written an article about the topic in the latest edition of DANSK BIOTEK magazine published in December 2018.

R&D Manager Monika Gad and Senior Scientist Jesper Larsen belong to the immunological research group at Bioneer. Measuring potency of medicinal products have long been one of the core assignments for the group. During the last couple of years Advanced Therapy Medicinal Products, so-called ATMPs, or cellular therapeutics have become increasingly popular. However, the lack of clear regulatory guidelines for potency testing remain to be an issue for clinicians as well as pharmaceutical and biotech companies developing new ATMPs.

Read more about ATMPs and what immunological parameters you can use as potency measurements in the latest DANSK BIOTEK magazine. If you have any questions, please contact R&D Manager Monika Gad via email or telephone +45 45 160 444.

To learn more about the immunological services and immune models present at Bioneer, press here

Link to the DANSK BIOTEK magazine No.4 2018 here. You will find the whole article on pages 4-6

Share this post